A Metabolic Disease Posing Severe Pancreatic Risks Gets Its First FDA-Approved Therapy

Ionis Pharmaceuticals’ Tryngolza is now the first approved therapy for treating severe hypertriglyceridemia, a prevalent chronic metabolic disorder that can lead to acute pancreatitis. This drug is a key piece of Ionis’s pivot away from partnering its assets, and instead developing and commercializing them on its own. The post A Metabolic Disease Posing Severe Pancreatic…

Read More

Culina Health Snags $7.9M to Expand Access to Nutrition Care

Culina Health’s Series A round was led by Healthworx, the investment arm of insurer CareFirst. It also included participation from Rethink Impact, Collab Capital, Collide Capital, Vamos Ventures, Tensility Venture Partners, Cake Ventures and GW Ventures. The post Culina Health Snags $7.9M to Expand Access to Nutrition Care appeared first on MedCity News.

Read More